Development of an Inflammatory CD14+ Dendritic Cell Subset in Humanized Mice

Humanized mouse models are attractive experimental models for analyzing the development and functions of human dendritic cells (DCs) in vivo. Although various types of DC subsets, including DC type 3 (DC3s), have been identified in humans, it remains unclear whether humanized mice can reproduce hete...

Full description

Bibliographic Details
Main Authors: Ryutaro Iwabuchi, Keigo Ide, Kazutaka Terahara, Ryota Wagatsuma, Rieko Iwaki, Hiroko Matsunaga, Yasuko Tsunetsugu-Yokota, Haruko Takeyama, Yoshimasa Takahashi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Immunology
Subjects:
DC3
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.643040/full
id doaj-28c899af954d40e2a23063a04dfd20a9
record_format Article
spelling doaj-28c899af954d40e2a23063a04dfd20a92021-03-15T05:48:32ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-03-011210.3389/fimmu.2021.643040643040Development of an Inflammatory CD14+ Dendritic Cell Subset in Humanized MiceRyutaro Iwabuchi0Ryutaro Iwabuchi1Ryutaro Iwabuchi2Keigo Ide3Keigo Ide4Kazutaka Terahara5Ryota Wagatsuma6Rieko Iwaki7Hiroko Matsunaga8Yasuko Tsunetsugu-Yokota9Yasuko Tsunetsugu-Yokota10Haruko Takeyama11Haruko Takeyama12Haruko Takeyama13Haruko Takeyama14Yoshimasa Takahashi15Department of Immunology, National Institute of Infectious Diseases, Tokyo, JapanDepartment of Life Science and Medical Bioscience, Waseda University, Tokyo, JapanComputational Bio Big-Data Open Innovation Laboratory, National Institute of Advanced Industrial Science and Technology, Tokyo, JapanDepartment of Life Science and Medical Bioscience, Waseda University, Tokyo, JapanComputational Bio Big-Data Open Innovation Laboratory, National Institute of Advanced Industrial Science and Technology, Tokyo, JapanDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, JapanDepartment of Life Science and Medical Bioscience, Waseda University, Tokyo, JapanDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, JapanResearch Organization for Nano and Life Innovation, Waseda University, Tokyo, JapanDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, JapanDepartment of Medical Technology, School of Human Sciences, Tokyo University of Technology, Tokyo, JapanDepartment of Life Science and Medical Bioscience, Waseda University, Tokyo, JapanComputational Bio Big-Data Open Innovation Laboratory, National Institute of Advanced Industrial Science and Technology, Tokyo, JapanResearch Organization for Nano and Life Innovation, Waseda University, Tokyo, JapanInstitute for Advanced Research of Biosystem Dynamics, Waseda Research Institute for Science and Engineering, Waseda University, Tokyo, JapanDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, JapanHumanized mouse models are attractive experimental models for analyzing the development and functions of human dendritic cells (DCs) in vivo. Although various types of DC subsets, including DC type 3 (DC3s), have been identified in humans, it remains unclear whether humanized mice can reproduce heterogeneous DC subsets. CD14, classically known as a monocyte/macrophage marker, is reported as an indicator of DC3s. We previously observed that some CD14+ myeloid cells expressed CD1c, a pan marker for bona fide conventional DC2 (cDC2s), in humanized mouse models in which human FLT3L and GM-CSF genes were transiently expressed using in vivo transfection (IVT). Here, we aimed to elucidate the identity of CD14+CD1c+ DC-like cells in humanized mouse models. We found that CD14+CD1c+ cells were phenotypically different from cDC2s; CD14+CD1c+ cells expressed CD163 but not CD5, whereas cDC2s expressed CD5 but not CD163. Furthermore, CD14+CD1c+ cells primed and polarized naïve CD4+ T cells toward IFN-γ+ Th1 cells more profoundly than cDC2s. Transcriptional analysis revealed that CD14+CD1c+ cells expressed several DC3-specific transcripts, such as CD163, S100A8, and S100A9, and were clearly segregated from cDC2s and monocytes. When lipopolysaccharide was administered to the humanized mice, the frequency of CD14+CD1c+ cells producing IL-6 and TNF-α was elevated, indicating a pro-inflammatory signature. Thus, humanized mice are able to sustain development of functional CD14+CD1c+ DCs, which are equivalent to DC3 subset observed in humans, and they could be useful for analyzing the development and function of DC3s in vivo.https://www.frontiersin.org/articles/10.3389/fimmu.2021.643040/fullhumanized micedendritic cellDC3CD14inflammatory responseS100A8
collection DOAJ
language English
format Article
sources DOAJ
author Ryutaro Iwabuchi
Ryutaro Iwabuchi
Ryutaro Iwabuchi
Keigo Ide
Keigo Ide
Kazutaka Terahara
Ryota Wagatsuma
Rieko Iwaki
Hiroko Matsunaga
Yasuko Tsunetsugu-Yokota
Yasuko Tsunetsugu-Yokota
Haruko Takeyama
Haruko Takeyama
Haruko Takeyama
Haruko Takeyama
Yoshimasa Takahashi
spellingShingle Ryutaro Iwabuchi
Ryutaro Iwabuchi
Ryutaro Iwabuchi
Keigo Ide
Keigo Ide
Kazutaka Terahara
Ryota Wagatsuma
Rieko Iwaki
Hiroko Matsunaga
Yasuko Tsunetsugu-Yokota
Yasuko Tsunetsugu-Yokota
Haruko Takeyama
Haruko Takeyama
Haruko Takeyama
Haruko Takeyama
Yoshimasa Takahashi
Development of an Inflammatory CD14+ Dendritic Cell Subset in Humanized Mice
Frontiers in Immunology
humanized mice
dendritic cell
DC3
CD14
inflammatory response
S100A8
author_facet Ryutaro Iwabuchi
Ryutaro Iwabuchi
Ryutaro Iwabuchi
Keigo Ide
Keigo Ide
Kazutaka Terahara
Ryota Wagatsuma
Rieko Iwaki
Hiroko Matsunaga
Yasuko Tsunetsugu-Yokota
Yasuko Tsunetsugu-Yokota
Haruko Takeyama
Haruko Takeyama
Haruko Takeyama
Haruko Takeyama
Yoshimasa Takahashi
author_sort Ryutaro Iwabuchi
title Development of an Inflammatory CD14+ Dendritic Cell Subset in Humanized Mice
title_short Development of an Inflammatory CD14+ Dendritic Cell Subset in Humanized Mice
title_full Development of an Inflammatory CD14+ Dendritic Cell Subset in Humanized Mice
title_fullStr Development of an Inflammatory CD14+ Dendritic Cell Subset in Humanized Mice
title_full_unstemmed Development of an Inflammatory CD14+ Dendritic Cell Subset in Humanized Mice
title_sort development of an inflammatory cd14+ dendritic cell subset in humanized mice
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2021-03-01
description Humanized mouse models are attractive experimental models for analyzing the development and functions of human dendritic cells (DCs) in vivo. Although various types of DC subsets, including DC type 3 (DC3s), have been identified in humans, it remains unclear whether humanized mice can reproduce heterogeneous DC subsets. CD14, classically known as a monocyte/macrophage marker, is reported as an indicator of DC3s. We previously observed that some CD14+ myeloid cells expressed CD1c, a pan marker for bona fide conventional DC2 (cDC2s), in humanized mouse models in which human FLT3L and GM-CSF genes were transiently expressed using in vivo transfection (IVT). Here, we aimed to elucidate the identity of CD14+CD1c+ DC-like cells in humanized mouse models. We found that CD14+CD1c+ cells were phenotypically different from cDC2s; CD14+CD1c+ cells expressed CD163 but not CD5, whereas cDC2s expressed CD5 but not CD163. Furthermore, CD14+CD1c+ cells primed and polarized naïve CD4+ T cells toward IFN-γ+ Th1 cells more profoundly than cDC2s. Transcriptional analysis revealed that CD14+CD1c+ cells expressed several DC3-specific transcripts, such as CD163, S100A8, and S100A9, and were clearly segregated from cDC2s and monocytes. When lipopolysaccharide was administered to the humanized mice, the frequency of CD14+CD1c+ cells producing IL-6 and TNF-α was elevated, indicating a pro-inflammatory signature. Thus, humanized mice are able to sustain development of functional CD14+CD1c+ DCs, which are equivalent to DC3 subset observed in humans, and they could be useful for analyzing the development and function of DC3s in vivo.
topic humanized mice
dendritic cell
DC3
CD14
inflammatory response
S100A8
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.643040/full
work_keys_str_mv AT ryutaroiwabuchi developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice
AT ryutaroiwabuchi developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice
AT ryutaroiwabuchi developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice
AT keigoide developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice
AT keigoide developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice
AT kazutakaterahara developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice
AT ryotawagatsuma developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice
AT riekoiwaki developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice
AT hirokomatsunaga developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice
AT yasukotsunetsuguyokota developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice
AT yasukotsunetsuguyokota developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice
AT harukotakeyama developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice
AT harukotakeyama developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice
AT harukotakeyama developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice
AT harukotakeyama developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice
AT yoshimasatakahashi developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice
_version_ 1724220932190371840